PharmacoEconomics & Outcomes News

, Volume 828, Issue 1, pp 15–15 | Cite as

Different approaches to assess benefits of oncology drugs

Non-clinical study


  1. Retzler J, et al. The impact of increased post-progression survival on the cost-effectiveness of interventions in oncology. ClinicoEconomics and Outcomes Research : 3 May 2019. Available from: URL:

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations